US Stock MarketDetailed Quotes
MRNA Moderna
- 43.060
- -0.330-0.76%
Close Nov 29 13:00 ET
- 43.100
- +0.040+0.09%
Post 17:01 ET
16.57BMarket Cap-7411P/E (TTM)
43.850High42.300Low3.59MVolume43.250Open43.390Pre Close155.26MTurnover1.04%Turnover RatioLossP/E (Static)384.82MShares170.47052wk High1.39P/B14.95BFloat Cap35.80052wk Low--Dividend TTM347.11MShs Float497.490Historical High--Div YieldTTM3.57%Amplitude11.540Historical Low43.229Avg Price1Lot Size
About Moderna Company
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5600
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500
Websitehttp://www.modernatx.com
Company Executives
- Name
- Position
- Salary
- Stephane Bancel
- Director and Chief Executive Officer
- 17.07M
- James M Mock
- Chief Financial Officer and Principal Accounting Officer
- 4.32M
- Brad Miller
- Chief Information Officer
- --
- Kate Cronin
- Chief Brand Officer
- --
- Tracey Franklin
- Chief Human Resources Officer
- --
- Shannon Thyme Klinger
- Chief Legal Officer and Corporate Secretary
- 4.31M
- Jerh Collins
- Chief Technical Operations and Quality Officer
- --
- Dr. Noubar B. Afeyan, PhD
- Chairman of the Board
- 663.52K
- Dr. Stephen Hoge, M.D.
- President
- 7.34M
- Abbas Hussain
- Director
- --
- David M. Rubenstein
- Director
- --
- Dr. Francois Nader, M.D.
- Independent Director
- 481.27K
- Dr. Elizabeth G. Nabel, M.D.
- Independent Director
- 476.25K
- Elizabeth E. Tallett
- Independent Director
- 481.27K
- Paul Sagan
- Independent Director
- 461.27K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 481.27K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
